Ara 290 and CJC-1295 (without DAC) Interaction

Synergistic
Mechanism-based 47% confidence

Ara 290 and CJC-1295 (without DAC) have a synergistic interaction with 47% confidence. Ara 290 and CJC-1295 (without DAC) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

Ara 290

Tissue-Protective Peptide | Innate Repair Receptor Agonist

Activates IRR through EPOR/β-common receptor complex, triggering tissue-protective signaling without erythropoietic effects..

Half-life: ~20 minutes (SubQ), ~2 minutes (IV) Typical dose: 4 mg daily healing, cognitive
epo receptor hematocrit raisingteratogenic
View full profile

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

Combined Organ Load

Blood Vessels
low
Brain
low
GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (Ara 290, CJC-1295 (without DAC)). Monitor accordingly.

Frequently Asked Questions

Can I take Ara 290 with CJC-1295 (without DAC)?

Yes, Ara 290 and CJC-1295 (without DAC) can generally be taken together. Ara 290 and CJC-1295 (without DAC) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is Ara 290 and CJC-1295 (without DAC) safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between Ara 290 and CJC-1295 (without DAC)?

Ara 290 and CJC-1295 (without DAC) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Ara 290 and CJC-1295 (without DAC)?

Ara 290 has a half-life of ~20 minutes (SubQ), ~2 minutes (IV) and CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Ara 290 vs CJC-1295 (without DAC)

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.